The protein measured in the developed test was neutrophil elastase (NE), which was quantitatively determined in the blood sera of patients with T2DM who had symptomatic COVID-19, with and without advanced diabetic nephropathy. This evidence concerns the gene ELANE and type 2 diabetes mellitus.